not that charts decide price, but OMVS would want to close

New Post Public Reply Private Reply Replies (0) Message Board
joey68 joey68 #105
784
not that charts decide price, but OMVS would want to close above .185 at least once in the next week in order to show this is not a possible downward trend.

Artificial Intelligence Technology Solutions Inc. (AITX) Stock Research Links

AITX Board Company Profile Buy Rating Time & Sales News Filings Financials
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hydrogen Mobility Gains Steam: Industry & Policy Unite

Updated Category News Views 1

The winds are changing, and this time, it's hydrogen that's blowing into town. Europe may just be on the brink of a major trucking overhaul, driven by a concoction of industry giants and supportive policies. The stage is set for hydrogen trucks to roll out by 2030, aiming to gut traditional fuel options and stack the odds in favor of zero-emission transport. Can you smell...

Continue Reading
MemoryDriver Relaunches with Navigation Challenge

Updated Category News Views 2

MemoryDriver's Relight: A Blazing New Course in Brain Health Look at this: Evon Medics is back with a bang, and they're handing us more than just another mind-numbing app update. On September 15, they're flipping the switch on MemoryDriver, their revamped brain-training gig, with a national 'Beat the Clock' Challenge. It’s up for grabs, totally free, and full of...

Continue Reading
Huawei Unleashes Bold New Flagship Devices in Munich

Updated Category News Views 1

Huawei's Bold Move in Munich When I hear about yet another product launch, I often roll my eyes but this one, folks, deserves a second glance. Huawei dropped a news bomb in Munich with their 'Chase the Wild' event, unveiling a huge lineup of flagship gadgets. This isn't your run-of-the-mill release; the mix of smart wearables, tablets, smartphones, and audio gear marks...

Continue Reading
Hamamatsu & AIxMed to Automate Cytology Workflows

Updated Category News Views 0

Why This Collaboration Matters Here comes an interesting tidbit from the world of cytology: Hamamatsu and AIxMed are banding together to tackle workflow inefficiencies. Picture this—two powerhouses coming together to create a tool that might just relieve lab technicians from the tedious task of manually checking cytology slides. In a world where efficiency is king, this...

Continue Reading
UNISORB Expands Reach with BILZ Acquisition

Updated Category News Views 2

UNISORB Acquisition: A Game-Changer for Industrial Solutions This ain't the first time a company took over another to expand its footprint, but UNISORB's latest move to scoop up BILZ-USA is worth a closer look. Everybody's talking about this takeover that throws UNISORB right into the spotlight of North America's industrial sector. Naming them the exclusive distributor of...

Continue Reading
Truist Revolutionizes Banking with 2 Billion Insights

Updated Category News Views 0

A New Frontier in Banking Truist is out here flipping the script in digital banking, pushing a staggering 2 billion AI-driven insights since 2023. Imagine that—two billion insights 'till now, providing the kind of financial street smarts that help folks feel less like they're lost at sea and more like they're the captain of their own financial ship, all thanks to Truist...

Continue Reading
Nanochon Tests Innovative Knee Implant in Human Trial

Updated Category News Views 2

Mending Knees with New Tech: The Chondrograft™ Debut Picture this: Nanochon's Chondrograft™ just hit the ground running. They've got a bite out of the future by diving headfirst into their First-in-Human (FIH) clinical study. This ain't your grandma's knee replacement talk. This is about changing the game for those knee cartilages that let out a groan every time you...

Continue Reading
XTransfer Revs Up Expansion in the UAE Market

Updated Category News Views 1

In the nitty-gritty world of B2B payments, securing a spot in a powerhouse like the UAE is no small potatoes. XTransfer just snagged an in-principle nod from the UAE Central Bank for a Retail Payment Services Licence, and that's got to feel like sweet validation for a company that's aggressively pushing its regulatory map beyond corners it's already conquered. Eyeing the...

Continue Reading
Pulnovo's PADN System Revolutionizes PH-LHD Treatment

Updated Category News Views 0

Pulnovo's Breakthrough in Heart Disease Management When Pulnovo Medical rolled out the PADN-HF-PH trial results at the ESC Congress 2026, seasoned investors like me sat up and took note. The trial, hot off the presses in The New England Journal of Medicine, unveiled how Pulmonary Artery Denervation (PADN) is throwing a wrench into the gears of conventional treatment of...

Continue Reading
Balázs Nagy's Bold Move: Transforming AI Workforce

Updated Category News Views 1

New Horizons in AI: Balázs Nagy Leads There's always that one name that shakes things up, and today it's Balázs Nagy. The guy's not just playing in the AI sandbox; he's leveling the whole thing up with Project NoéMI. He's the big cheese at TheNewPush LLC, beyond just a job title. Nagy’s diving headfirst into AI workforce development in a world screaming for change....

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding the Key Disclosures for Assura Plc Investors

Updated Category News Views 114

Understanding Key Information About Assura Plc In the dynamic world of investments, transparency is vital. One of the key aspects of tracking investments, especially in publicly traded companies, is understanding the disclosures made regarding ownership and dealings in relevant securities. For Assura Plc, a leading name in the healthcare property sector, effective...

Continue Reading
DFDS Reports Freight Growth Across Key European Routes

Updated Category News Views 155

DFDS Reports Freight Growth Across Key European Routes Ferry – freight: In a notable enhancement, DFDS reported total freight volumes in May reaching 3.7 million lane meters, surpassing 2024 figures by 4.5%, while adjustments for route changes showed an increase of 2.5%. Year-to-date (YTD) growth was slightly positive at 0.6% unadjusted, however showing a minor decrease...

Continue Reading
GLOBO Language Solutions Expands Management to Drive Growth

Updated Category News Views 135

GLOBO Language Solutions Expands Management to Drive Growth GLOBO Language Solutions, a prominent provider of interpreting and translation services, has recently made notable executive promotions within its ranks. This strategic move highlights the company’s commitment to strengthening its leadership in the face of ongoing operational growth. Matthew Ficca, previously...

Continue Reading
Lakeland Fire + Safety Secures $5.6 Million Deal in Asia

Updated Category News Views 175

Lakeland Fire + Safety Secures Major Contract in Asia New agreement enhances decontamination and maintenance services for firefighter gear. HUNTSVILLE, Ala. — Lakeland Industries, Inc. (NASDAQ: LAKE), renowned for manufacturing protective clothing, recently announced an impressive USD $5.6 million contract awarded to its subsidiary, Lakeland LHD. This agreement focuses...

Continue Reading
Banco Comercial Português Reports Promising 2024 Earnings

Updated Category News Views 136

Banco Comercial Português, S.A. Reports Its 2024 Earnings Banco Comercial Português, S.A., one of the major banking institutions, has unveiled its consolidated earnings for the year 2024. The financial results highlight a strong performance, indicating the bank's resilience and adaptability in a competitive marketplace. Overview of Earnings The bank exhibited robust...

Continue Reading